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RESEARCH
The role of phagocytic leukocytes 
following flexible ureterenoscopy, 
for the treatment of kidney stones: 
an observational, clinical pilots-study
Stephen Fôn Hughes1,2* , Alyson Jayne Moyes1,2,3, Rebecca May Lamb1, Peter Ella‑tongwiis1,2, 
Nana Yaa Frempomaa Snyper1,2 and Iqbal Shergill1,2,4
Abstract 
Background: The number of patients undergoing flexible ureterenoscopy (FURS) for the treatment of kidney stones 
(renal calculi) is increasing annually, and as such the development of post‑operative complications, such as acute 
kidney injury (AKI), haematuria and infection is likely to increase. Phagocytic leukocytes are white blood cells that help 
fight foreign material such as bacteria and viruses, and they are intrinsically involved in the inflammatory reaction. 
Investigating the role of phagocytic leukocytes following FURS has not been widely researched. The main aim of the 
study was to evaluate the role phagocytic leukocytes (neutrophils and monocytes) function, in patients undergoing 
FURS for the treatment of kidney stones (renal calculi).
Methods: Fourteen consecutive patients aged between 27 and 70 years (median 49.5 years) undergoing FURS for 
the treatment of kidney stones were recruited (seven males, seven females). Blood samples were collected from each 
patient at four time points: baseline (pre‑operatively) followed by 30, 120 and 240 min post‑operatively. Mononu‑
clear (MN) and polymorphonuclear (PMN) leukocyte sub‑populations were isolated by density gradient centrifuga‑
tion techniques. Neutrophil and monocyte cell function was investigated by measuring the cell surface expression 
of CD62L (L‑selectin), CD11b (Mac‑1), CD99 and the intracellular production of hydrogen peroxide  (H2O2), via flow 
cytometry.
Results: Significant increases was observed in monocyte CD62L expression post FURS for the treatment of kidney 
stones (p ≤ 0.05); while significant decreases were observed in neutrophil CD62L. The levels of the other activation 
markers CD11b, CD99 and  H2O2 corresponded to the increases and decreases seen in CD62L for monocytes and 
neutrophils respectively, though the changes were not statistically significant (p > 0.05). Limiting factors for this study 
were the relatively small sample size, and restriction on the recruitment time points.
Conclusions: This study demonstrates that following FURS for the treatment of kidney stones, monocytes are rapidly 
activated and produce potent reactive oxygen intermediates. Interestingly, the pattern of expression in neutrophils 
suggests that these cells are deactivated in response to the treatment. The leukocyte biomarkers assessed during this 
investigation may have a role in monitoring the ‘normal’ post‑operative response, as no complications occurred in any 
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Background
Kidney stone disease (nephrolithiasis) contributes to 
a significant proportion of routine urological practice 
and remains a common cause of worldwide morbidity 
[1]. Globally, the average lifetime risk of developing kid-
ney stones (renal calculi) is 5–10% [2]. However, indus-
trialised countries exhibit higher incidence rates, with 
the male lifetime risk of developing kidney stones being 
18.8% and the female risk being 9.4% [3]. Alarmingly, 
both the incidence and prevalence of kidney stones con-
tinues to rise, irrespective of age, race or gender [4–7]. 
Furthermore, it can be appreciated that with an increase 
in kidney stone incidences, comes an increase in the 
demand for treatment, which in turn, escalates the pro-
portion of patients who may develop a post-operative 
complication as a result of intervention.
The number of patients undergoing flexible ureterenos-
copy (FURS) for the treatment of kidney stones is increas-
ing annually. The overall complication rate after FURS is 
9–25% [8]. Following FURS, there is a risk of developing 
post-operative complications such as infection, bleeding, 
renal injury, sepsis and pain [9]. With an annual increase 
in the number of patients undergoing FURS surgery, 
it is expected that the instances of such complications 
will also increase, and if left untreated, these complica-
tions may be fatal [10]. Although it recognised that FURS 
is a generally successful, minimally invasive means of 
removing stones, the primary consideration in managing 
stones must be diverted from analysing stone free rates: 
to instead focus on the process of removing stones with 
minimal complications, to reduce the incidences of asso-
ciated morbidities. It is, therefore, imperative that health-
care providers have a means to confidently predict those 
patients who undergo surgery, who are likely to develop 
post-operative complications such as obstructed kidneys, 
infection or subsequent urosepsis.
Conventionally in the UK, patients undergoing urologi-
cal surgery have been post-operatively monitored using 
C reactive protein (CRP) and erythrocyte sedimentation 
rate (ESR), which are established markers of inflamma-
tion [11]. However, the disadvantage to measuring these 
markers is their non-specific nature [12], resulting in an 
inability to differentiate between inflammations due to 
inter-current or pre-existing disease processes, to those 
arising as a direct complication of treatment or surgery.
Phagocytic leukocytes are components of the non-
specific immune system. Monocytes and neutrophils 
are examples of phagocytic leukocytes and it can be 
appreciated that they play a key role during inflamma-
tion due to their adhesion, trans-endothelial migration 
and subsequent activation into the surrounding tissues 
[13, 14]. They are important cells that are able to medi-
ate tissue damage with vital involvement in modulation 
of host defence via the innate immune response, they can 
internalise and destroy potentially harmful pathogens 
and infectious agents via phagocytosis [14]. Leukocytes 
are intrinsically involved with the vascular endothelium, 
and express specific adhesion molecules (e.g. CD62L, 
CD11b, CD99) on their cell surfaces for facilitating such 
interactions. During cellular activation, leukocytes pro-
duce and release potent proteolytic enzymes and reac-
tive oxygen intermediates [13–15], which may contribute 
toward some of the post-operative complications that can 
develop following FURS. Both neutrophils and mono-
cytes have been implicated to play a key role during the 
inflammatory response post-surgery and thus deserve 
research attention [16–18].
CD62L (L-selectin) is an adhesion molecule that is 
part of the selectin family. It is a cell surface glycoprotein 
that is expressed on the cell surface of most leukocytes. 
CD62L has a vital role in leukocyte migration. CD62L 
has a shedding mechanism, in an attempt to regulate the 
rate at which leukocyte extravasation occurs in inflamed 
tissues [19].
CD11b (Mac-1) is a member of the integrin fam-
ily and is expressed on the cell surface of the majority 
of leukocytes, including macrophages, monocytes and 
neutrophils as well as natural killer cells [20]. CD11b’s 
functional role involves adhesion and migration of acti-
vated leukocytes in response to inflammatory stimulus 
[13, 21, 22].
CD99 is a glycoprotein that is expressed on most leu-
kocyte cells. CD99 has a unique role and is involved in 
the homophylic interactions during trans-endothelial 
migration. Raised levels of neutrophil CD99 levels were 
recently reported in a cohort of patients with inflamma-
tory bowel disease, thus indicating that CD99 is directly 
involved to inflammatory responses [23].
Hydrogen peroxide is a strong oxidising agent and 
is produced by phagocytic cells such as monocytes and 
neutrophils. Increased intracellular production of  H2O2 
levels has been reported following various orthopaedic 
surgical interventions, but as yet have not been reported 
following FURS [16, 17]. The present study was designed 
of the patients; or may help predict potential infectious complications (e.g. urosepsis) that can occur during the post‑
operative period. This data, however, will need to be validated and reproduced in larger multi‑centre studies.
Keywords: Flexible ureterenoscopy, (FURS), Flow cytometry, Kidney stones, Inflammation, Biomarkers, Leukocytes
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to ascertain whether FURS for the treatment of kidney 
stones results in changes to neutrophils and monocytes 
cell surface expression of the CD62L, CD11b and CD99 
adhesion molecules, and to assess the intracellular pro-
duction of  H2O2.
Whilst we, and others, have previously reported post-
operative changes in routine blood tests (haematological 
and biochemical) following various urological surgical 
procedures [24–26], crucially, there is very little evidence 
investigating the direct effect of FURS on leukocyte func-
tion. An important aspect of this clinical pilot-study was 
to provide a better understanding of the role of phago-
cytic leukocytes following FURS. Specifically, we aimed 
to evaluate changes in leukocyte function to provide a 
better understanding of their post-operative course fol-
lowing elective FURS, for the treatment kidney stones. 
It was our expectation to enhance current urological lit-
erature by adding a evidence based insight on this topic, 
and to provide findings that may ultimately aid clinicians 
in distinguishing the ‘normal’ post-operative response to 
those at increased risk of complications such as infection 
following FURS; however, the validation and reliability 
needs to be assessed through larger cohort studies.
Methods
Subject volunteers
Ethical approval for this study was received from the 
Welsh Research Ethics Service (REC) 4 committee 
(REC4: 12/WA/0117). Fourteen consecutive patients, 
scheduled for elective FURS for the treatment of kid-
ney stones were recruited (n = 14). Specifically, seven 
males and seven females aged between 27 and 70  years 
(median 49.5 years) were recruited after receiving written 
informed consent.
Flexible ureterenoscopy (FURS) and blood collection
Treatment was given as per standardised protocol at 
the Betsi Cadwaladr University Health Board (BCUHB) 
Wrexham Maelor, NHS hospital, North Wales, UK under 
the same consultant urologist. An Olympus P5 Flexible 
Ureterorenoscopy was used during the surgery, while 
patients were under general anaesthesia using Propo-
fol. The mean FURS procedure time was 58  min (22–
104  min). Complete stone clearance was achieved in all 
patients, with no complications reported post-treatment.
Prior to FURS, a venous blood sample was collected 
pre-operatively from the arm via the antecubital fossa 
Blood samples were collected into di-potassium ethylene 
diamine tetra-acetic acid (EDTA), which stood as a base-
line (control) measurement. The baseline (pre-operative) 
samples served as the control measures during this study, 
with the main aim being to compare the effects of FURS 
on the leukocyte parameters measured within each sub-
ject pre and post-operatively.
Following FURS, further blood samples were taken at 
30, 120 and 240  min post-operatively. The fresh blood 
samples were then isolated within 4 h and used for flow 
cytometric analysis of Cluster of Differentiation (CD) 
markers: CD99, CD11b, CD62L and intracellular produc-
tion of  H202.
With regards to the choice of anticoagulant used dur-
ing blood collection procedures in the present study, 
previous studies have reported that blood collected in 
heparin lead to cellular activation and increased expres-
sion of CD11b in comparison to cells in blood drawn 
into EDTA [27]. Interestingly, Patil et al. [28] found that 
the levels of a number of cytokines (i.e. IL-6, IL-8, IL-10, 
IL-17, MIP-1β, GM-CSF and MCP-1) were significantly 
higher in blood samples collected in heparin compared 
to those collected in EDTA. With regard to the present 
study, all blood samples were collected into EDTA vacu-
tainers to avoid any unnecessary leukocyte activation.
Isolation of leukocytes
Phagocytic leukocytes were isolated from whole blood 
samples. The blood was collected in EDTA vacutainers, 
and the mononuclear cell (MN) and polymorphonuclear 
cells (PMN) were separated using a density-gradient cen-
trifugation method using Ficoll-Hypaque solutions sup-
plied by Sigma, UK.
Isolated PMN and MN were then counted using a 
Beckman Coulter DxH 500 (Beckman Coulter, UK) to 
establish the purity and total numbers (Fig.  1). Subse-
quently, cell counts were adjusted to 2 × 106  cells/ml 
with PBS/EDTA before immediate measurement using 
the Becton Dickinson (BD) Accuri C6 flow cytometer 
(Beckman Dickinson, New Jersey, USA), which had been 
initially validated and gated for the analysis of leukocyte 
Fig. 1 Efficiency of leukocyte isolation methods. Percentage yields 
of MN and mononuclearand PMN granulocyte cells was calculated 
following measurement using a Beckman DxH 500. Results are 
presented as means ± SD
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subpopulations (Fig. 2). The isolated cells were analysed 
within 4 h to ensure live cell viability.
Measurement of cell surface expression of CD62L, CD11b 
and CD99
Commercially optimised monoclonal antibodies used 
were mouse anti-human CD99 (MCA1850), CD62L 
(MCA1076F) and CD11b (MCA551F), along with their 
isotype-matched controls. All reagents were purified 
immunoglobulin/fluorescein isothiocyanate (Ig/FITC) 
conjugates supplied from Bio-Rad, UK (formerly AbD 
Serotec).
Isolated leukocyte subpopulations PMN and MN were 
incubated in monoclonal antibodies at 0.1  mg/ml for 
30 min at room temperature, prior to assay analysis using 
flow cytometry of gated monocytes and neutrophils 
(Fig. 2). Changes in the cell surface expression of CD62L, 
CD11b and CD99 (represented by mean fluorescent 
intensity) were measured at each time interval to assess 
the effect of FURS on phagocytic cell function.
Measurement of intracellular hydrogen peroxide production 
 (H2O2)
Cells were isolated and intracellular  H2O2 production was 
assessed by adaptation of a technique originally described 
by Bass et al. [30]. The assay was based on the oxidation 
of non-fluorescent 2′, 7′-dichlorofluoroscin diacetate 
(DCFH-DA) by  H2O2 to stable and fluorescent dichloro-
fluoroescein.  H2O2 production was assessed in cells using 
a fixed volume of 0.5 ml cell suspension (2 × 106 cells/ml) 
mixed with 0.5 ml DCFH-DA (20 µM) in PBS. Cells were 
incubated in the dark, at 37 °C for 30 min before imme-
diate measurement using flow cytometry of gated mono-
cytes and neutrophils (Fig. 2).
Statistical analysis
Statistical analysis for this clinical pilot-study was car-
ried out using SPSS for Windows, version 24. Initial 
testing for normal distribution was carried out on 
all sample populations, with results being measured 
against the Kolmogorov–Smirnov, with data being clas-
sified as normally distributed if p ≥ 0.05.
Where data were parametric, repeated measures one-
way analysis of variance (ANOVA) between samples 
test was employed, adopting a 5% level of significance. 
Post hoc testing was conducted using the Bonferroni 
test for pairwise comparisons between means. All para-
metric data are presented as mean ± standard deviation 
(SD).
Data that did not comply with normality were ana-
lysed using the Friedman test. Where the Friedman 
test resulted in statistical significance, subsequent tests 
were performed using the Wilcoxon test. Statistical 
significance was accepted when p ≤ 0.05. All non-par-
ametric results are presented as median ± interquartile 
range (Iqr).
Results
Efficiency of the leukocyte isolation method
The efficiency of the leukocyte isolation method is 
illustrated in Fig.  1. The percentage isolation yield of 
the mononuclear (monocyte and lymphocyte) cells 
(94.2 ± 12.7%) was slightly higher than that for the 
PMN cells (90.9 ± 6.73%). The low erythrocyte presence 
in the isolated cells (0.01 ± 0.002%) indicates that the 
isolation method was effective, as there is minimal con-
tamination of red blood cells present. The isolated MN 
and PMN cell populations were subsequently analysed 
via flow cytometry.
The effect of FURS on CD62L cell surface expression 
of neutrophils and monocyte
The results are expressed as Mean Fluorescent Intensity 
(MFI) and represent changes to the CD62L cellular sur-
face expression in both neutrophils and monocytes, both 
pre-operatively (baseline) and after FURS (30, 120 and 
240  min post-operatively), for the treatment of kidney 
stones.
ANOVA analysis results show a statistically sig-
nificant decrease in the expression of CD62L in neu-
trophils, p = 0.042 (Fig.  3). Baseline levels of CD62L, 
(38,554 ± 2,644 MFI), increased at 30 (45,715 ± 4,661 
MFI), then decreased at 120 (42,130 ± 2,902 MFI) and 
240 min post-op (36,610 ± 2,988 MFI). Post hoc Bonfer-
roni testing showed that there was no significant differ-
ence in the production of  H202 between baseline vs 30, 
120 and 240 min post-FURS (p > 0.05).Fig. 2 Example gating of leukocyte subpopulations during flow 
cytometric analysis, employing the BD Accuri C6 flow cytometer
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The CD62L cell surface expression on monocytes 
increased from the baseline value (40,828 ± 32,29 
MFI) following FURS at 30 (53,107 ± 4299 MFI), 120 
(60,732 ± 7,643 MFI), and decreased at 240 min post-op 
(58,402 ± 7,861 MFI). The increasing pattern observed 
in CD62L cell surface expression on monocytes, was 
found to be significant using ANOVA testing p = 0.006 
(Fig.  3). Post hoc Bonferroni testing showed that there 
was significant difference in CD62L between baseline vs 
30 (p = 0.023), 120 (p = 0.011) and 240 (p = 0.08) minutes 
post-FURS.
The effect of FURS on CD11b cell surface expression 
of neutrophils and monocytes
The results are expressed as Mean Fluorescent Intensity 
(MFI) and represent changes to the CD11b cellular sur-
face expression in both monocytes and neutrophils, both 
pre-operatively (baseline) and after FURS (30, 120 and 
240  min post-operatively), for the treatment of kidney 
stones.
Friedman analysis results showed no statistically sig-
nificant increases in the expression of CD11b in neu-
trophils, p = 0.593 (Fig.  4). Baseline levels of CD11b 
(45,547 ± 36,839 MFI), decreased at 30 (36,300 ± 31,090 
MFI), and increased at 120  min (40,240 ± 31,432 MFI) 
and at 240 min post-operatively (40,978 ± 24,717 MFI).
The CD11b cell surface expression on monocytes 
increased from the baseline (51,873 ± , 5,031 MFI) 
following FURS at 30 (57,691 ± 6,316 MFI) and at 120 
(60,972 ± 9,034 MFI) minutes post-operatively. At 
240  min post-operatively (54,003 ± 6,638 MFI) CD11b 
cell surface expression decreased toward balsa levels. 
However, changes in CD11b cell surface expression on 
monocytes, was found not to be significant via ANOVA 
analysis p = 0.356 (Fig. 4).
The effect of FURS on CD99 cell surface expression of 
neutrophils and monocytes
The results are expressed as Mean Fluorescent Intensity 
(MFI) and represent changes to the CD99 cellular sur-
face expression in both monocytes and neutrophils, both 
pre-operatively (baseline) and after FURS (30, 120 and 
240  min post-operatively), for the treatment of kidney 
stones.
Friedman analysis results showed no signifi-
cant decrease in the expression of CD99 in neu-
trophils, p = 0.138 (Fig.  5). Baseline levels of CD99 
(32,223 ± 22,728 MFI) decreased at 30 (26,830 ± 14,255 
MFI), 120 (19,591 ± 16,671 MFI) and 240 min post-oper-
atively (18,739 ± 12,934 MFI).
The CD99 cell surface expression on mono-
cytes increased initially from the baseline value 
(62,273 ± 57,396 MFI) following FURS at 30  min 
(70,173 ± 57,745 MFI), and at 120 min (81,935 ± 72,138) 
post-operatively. However, CD99 expression decreased 

































Fig. 3 Effect of flexible ureterenoscopy on CD62L cell surface expression of neutrophils and monocytes. The points represent mean ± SD


































Fig. 4 Effect of flexible ureterenoscopy on CD11b cell surface expression of neutrophils and monocytes. The points represent median ± Iqr 


































Fig. 5 Effect of flexible ureterenoscopy on CD99 cell surface expression of neutrophils and monocytes. The points represent median ± Iqr
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changes observed in CD99 cell surface expression on 
monocytes, were found not to be significant using Fried-
man testing p = 0.078 (Fig. 5).
The effect of FURS on intracellular production of  H202 
of neutrophils and monocytes
The results are expressed as Mean Fluorescent Intensity 
(MFI) and represent changes seen in levels of intracellu-
lar  H202 production in both monocytes and neutrophils, 
both pre-operatively (baseline) and after FURS (30, 120- 
and 240-min post-op), for the treatment of kidney stones.
Friedman analysis results showed no significant 
changes in  H202 production in neutrophils, p = 0.082 
(Fig.  6). Specifically, there was an increase from base-
line levels of  H202 (89,527 ± 54,958 MFI) at 30 min post-
operatively (98,804 ± 75,880 MFI). However, there was a 
decrease in  H202 production at 120 (93,227 ± 62,919 MFI) 
and 240 min (76,283 ± 45,955 MFI) post-operatively.
There was an increase in intracellular  H202 produc-
tion of monocyte cells from baseline (128,102 ± 52,593 
MFI) to 30 (149,953 ± 71,204 MFI) and 120  min 
(168,859 ± 88,390 MFI) post-operatively. However, at 
240 min the  H202 levels decreased back towards the basal 
value (150,951 ± 82,084 MFI). However, analysis of the 
data via ANOVA found the changes observed not to be 
significant, p = 0.075 (Fig. 6).
Discussion
The main aim of this study was to evaluate the role of 
phagocytic leukocytes (neutrophils and monocytes) in 
patients undergoing FURS for the treatment of kidney 
stones. It can generally be appreciated that damage 
occurs to the vascular endothelium following FURS, 
due to the passage, and consequential stone removal 
with a flexible ureterenoscope. Consequently, it is spec-
ulated that leukocyte margination will occur at sites of 
trauma, subsequently leading to leukocyte activation. 
In order to establish the role of monocytes and neutro-
phils following FURS, cell surface adhesion molecules 
CD62L, CD11b, CD99 and intracellular production of 
 H2O2 were assessed.
The present study reports of changes to neutrophils 
and monocytes cell surface expression of CD62L, 
CD11b and CD99 following FURS, which is associated 
with leukocyte cell activation (Table 1). This was further 
supported by the increase in intracellular  H2O2  pro-
duction of neutrophils and monocytes. It can also 
be appreciated that during leukocyte activation fur-































Fig. 6 Effect of flexible ureterenoscopy on  H202 on cell surface expression of neutrophils and monocytes. The points represent mean ± SD 
(neutrophils) and median ± Iqr (monocytes)
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intermediates (e.g. myeloperoxidase and superoxide) 
and proteolytic enzymes (e.g. elastase) are released 
extracellularly [13, 22]. Collectively, the actions of these 
degradative substances may potentially cause consider-
able damage to host tissue, prolong the inflammatory 
response following FURS and may play an integral role 
in the development of post-operative complications.
With regard to the work undertaken by Moyes et al. 
[24], who evaluated changes to haematological and 
biochemical blood tests after FURS for the treatment 
of kidney stones, the present study compliments this 
work and provides a further insight into the role of 
phagocytic leukocytes pertaining to the ‘normal’ post-
operative response following FURS, as no complica-
tions were reported in any of the patients in the present 
study. Data reported from the present study also follow 
a similar trend of leukocyte activation that has been 
previously reported by Hughes et al. [16, 17] following 
upper and lower limb orthopaedic surgeries.
We report that selective phagocytic leukocyte biomark-
ers such as CD62L, CD11b, CD99 and  H2O2  may pro-
vide alternative ways of monitoring patients during the 
post-operative period following FURS. It is, therefore, 
proposed that by allowing urological surgeons access to 
these laboratory markers, an accurate assessment of the 
extent of inflammation following surgery per se may be 
made. The leukocyte biomarkers assessed during this 
investigation may have a role in monitoring ‘normal’ 
response and to help predict potential infectious com-
plications (e.g. urosepsis) that can occur during the post-
operative period.
This is the first study to report on the role of phagocytic 
leukocytes to following FURS for the treatment of kidney 
stones. However, in order to fully understand the role of 
phagocytic leukocytes following FURS, further studies 
involving larger cohorts and longer post-operative moni-
toring and blood sampling (e.g. 4–24 + hours) is needed. 
Furthermore, it is acknowledged that a limiting factor of 
this pilot-study is the relatively small number of partici-
pants recruited (n = 14). For future studies involving flow 
cytometry, it would be beneficial to employ monoclonal 
antibodies specific for a particular cell type (e.g. CD14 
and CD64 for the identification of mature monocyte pop-
ulations). Nevertheless, we feel that these observational 
findings provide encouragement for further exploration 
into the role of phagocytic leukocytes and its correlation 
with clinical outcome measures (e.g. infection), in larger 
cohorts following FURS. Although none of the patients 
during this study had an untoward outcome, it would be 
beneficial for future investigations to include a control 
other than the patients themselves, for example by com-
paring patients undergoing shock wave lithotripsy, which 
is a non-invasive procedure for the treatment of small 
kidney stones. This would provide an alternative control 
measure and help generate unique results to establish the 
extent of inflammation and changes to phagocytic leu-
kocyte function following both procedures. In turn, this 
may also help fully understand the attributing effects that 
anaesthesia may have on patients’ blood for those under-
going FURS.
Ultimately, if changes to leukocyte function following 
FURS can identify or predict those patients at increased 
risk of complications such as bleeding and infection, 
future directions of this study may offer the potential of 
pharmacological intervention. For example, using anti-
haemorrhagic agents as preventative measures for post-
operative bleeding or providing antimicrobial agents 
for infection could improve patients’ recovery following 
FURS for the treatment of kidney stones.
Conclusion
This study demonstrates that following FURS for the 
treatment of kidney stones, monocytes are rapidly acti-
vated and produce potent reactive oxygen intermediates. 
Interestingly, within the time points studied, it appears 
that neutrophils undergo down-regulation of the activa-
tion markers suggesting that their role in the response 
to the treatment is different from that of the monocytes. 
The leukocyte biomarkers assessed during this investi-
gation may have a role in monitoring the ‘normal’ post-
operative response, as no complications occurred in any 
of the patients; or may help predict potential infectious 
complications (e.g. urosepsis) that can occur during the 
post-operative period. These data, however, will need 
to be validated and reproduced in larger multi-centre 
studies.
Table 1 Summary of main findings
Statistically significant increases were observed in monocyte CD62L expression post FURS for the treatment of kidney stones (p ≤ 0.05)
Statistically significant decreases were observed in neutrophil CD62L expression post FURS for the treatment of kidney stones (p ≤ 0.05)
No statistically significant changes were seen in neutrophils and monocytes CD11b, CD99 and  H202 levels, post FURS for the treatment of kidney stones 
(p ≥ 0.05). Though trend mirrored CD62L
Monocytes consistently expressed more cell surface expression of CD62L, CD11b, CD99 and produced more intracellular  H202 following FURS com‑
pared to neutrophils
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Abbreviations
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